Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Shares Outstanding (Weighted Average) (2020 - 2021)

Historic Shares Outstanding (Weighted Average) for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $55.2 million.

  • Design Therapeutics' Shares Outstanding (Weighted Average) rose 11459.65% to $55.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $55.2 million, marking a year-over-year increase of 11459.65%. This contributed to the annual value of $15.8 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q3 2021, Design Therapeutics' Shares Outstanding (Weighted Average) is $55.2 million, which was up 11459.65% from $55.1 million recorded in Q2 2021.
  • Design Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $55.2 million for Q3 2021, and its period low was $15.7 million during Q1 2020.